Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy

This study has been terminated.

Sponsor:

Information provided by:

Mario Negri Institute for Pharmacological Research

ClinicalTrials.gov Identifier:

NCT00157508

First received: September 8, 2005

Last updated: November 18, 2005

Last verified: September 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	August 2004
Estimated Primary Completion Date:	No date given